stella
beta
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer — Stella
Recruiting
Back to Ovarian Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing
View full record on ClinicalTrials.gov